ConductScience.org, home
An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
API referenceFor AI assistants

Trial · NCT02590432

Participant flow81

How many started, completed or left each group, period by period.

1 to 20 of 81

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Open-label Treatment PeriodSTARTEDLINZESS® 145 μg (CIC, Open Label)508
Open-label Treatment PeriodSTARTEDLINZESS® 290 μg (IBS-C, Open Label)318
Open-label Treatment PeriodSTARTEDLINZESS® 290 μg (IBS-C, Double Blind)0
Open-label Treatment PeriodSTARTEDLINZESS® 145 μg (IBS-C, Double Blind)0
Open-label Treatment PeriodSTARTEDLINZESS® 72 μg (IBS-C, Double Blind)0
Open-label Treatment PeriodSTARTEDLINZESS® 145 μg (CIC, Double Blind)0
Open-label Treatment PeriodSTARTEDLINZESS® 72 μg (CIC, Double Blind)0
Open-label Treatment PeriodSTARTEDLINZESS® 72 μg (CIC, Dose-reduced Open Label)0
Open-label Treatment PeriodSTARTEDLINZESS® 72 μg (IBS-C, Dose-reduced Open Label)0
Open-label Treatment PeriodCOMPLETEDLINZESS® 145 μg (CIC, Open Label)276
Open-label Treatment PeriodCOMPLETEDLINZESS® 290 μg (IBS-C, Open Label)166
Open-label Treatment PeriodCOMPLETEDLINZESS® 290 μg (IBS-C, Double Blind)0
Open-label Treatment PeriodCOMPLETEDLINZESS® 145 μg (IBS-C, Double Blind)0
Open-label Treatment PeriodCOMPLETEDLINZESS® 72 μg (IBS-C, Double Blind)0
Open-label Treatment PeriodCOMPLETEDLINZESS® 145 μg (CIC, Double Blind)0
Open-label Treatment PeriodCOMPLETEDLINZESS® 72 μg (CIC, Double Blind)0
Open-label Treatment PeriodCOMPLETEDLINZESS® 72 μg (CIC, Dose-reduced Open Label)0
Open-label Treatment PeriodCOMPLETEDLINZESS® 72 μg (IBS-C, Dose-reduced Open Label)0
Open-label Treatment PeriodNOT COMPLETEDLINZESS® 145 μg (CIC, Open Label)232
Open-label Treatment PeriodNOT COMPLETEDLINZESS® 290 μg (IBS-C, Open Label)152

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02590432/flow

API referenceFor AI assistants